Aperio GT 450 DX; Aperio GT 180 DX
K-Number: K253554 · 2026-08-07
Device Summary
Frequently Asked Questions
What is the Aperio GT 450 DX; Aperio GT 180 DX?
Aperio GT 450 DX; Aperio GT 180 DX is a medical device that received FDA 510(k) clearance on 2026-08-07. The listed applicant is Leica Biosystems Imaging, Inc.. The 510(k) number is K253554.
When did Aperio GT 450 DX; Aperio GT 180 DX receive FDA 510(k) clearance?
Aperio GT 450 DX; Aperio GT 180 DX received FDA 510(k) clearance on 2026-08-07, under 510(k) number K253554.
Who is the listed applicant for Aperio GT 450 DX; Aperio GT 180 DX?
The FDA 510(k) record lists Leica Biosystems Imaging, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Aperio GT 450 DX; Aperio GT 180 DX?
The FDA product code for Aperio GT 450 DX; Aperio GT 180 DX is PSY.
Other records listing Leica Biosystems Imaging, Inc. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: PSY)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.